Lineage Cell Therapeutics
LCTX
#8906
Rank
โ‚ฌ0.17 B
Marketcap
0,70ย โ‚ฌ
Share price
-5.87%
Change (1 day)
-53.43%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2026 (TTM): -0,23ย โ‚ฌ

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,25ย โ‚ฌ. In 2019 the company made an earnings per share (EPS) of -0,03646ย โ‚ฌ an increase over its 2018 EPS that were of -0,32ย โ‚ฌ.

EPS history for Lineage Cell Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,23ย โ‚ฌ
2019-0,03646ย โ‚ฌ-88.57%
2018-0,32ย โ‚ฌ
20160,29ย โ‚ฌ
2014-0,51ย โ‚ฌ
2012-0,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA